Trial intelligence / Profile preview

PK and Safety of A006 in Healthy Volunteers

NCT02271334Phase 2Completed

Start
Aug 2014
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of A006 in asthma (4 arms). Primary endpoints: Area Under the Curve of Drug Concentration versus Time (0-t), Peak Plasma Concentration and 2 more. Started Aug 2014; status: completed.

02

Drugs

A006
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02271334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02271334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call